Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 64.16B | 62.50B | 51.42B | 58.39B | 51.73B | 41.96B |
Gross Profit | 28.54B | 26.34B | 22.34B | 27.19B | 24.39B | 19.00B |
EBITDA | 13.53B | 14.27B | 10.78B | 15.24B | 14.05B | 8.93B |
Net Income | 9.23B | 9.43B | 6.50B | 10.59B | 9.16B | 5.61B |
Balance Sheet | ||||||
Total Assets | 100.09B | 90.91B | 84.14B | 80.10B | 76.32B | 66.26B |
Cash, Cash Equivalents and Short-Term Investments | 27.02B | 27.86B | 34.93B | 36.24B | 36.56B | 31.32B |
Total Debt | 10.00B | 494.00M | 291.00M | 352.00M | 262.00M | 144.00M |
Total Liabilities | 23.20B | 14.01B | 11.57B | 11.09B | 13.35B | 10.17B |
Stockholders Equity | 76.09B | 76.12B | 72.58B | 69.01B | 62.97B | 56.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 413.00M | 3.71B | 5.62B | 7.68B | 7.46B |
Operating Cash Flow | 0.00 | 12.99B | 7.45B | 7.38B | 9.30B | 8.74B |
Investing Cash Flow | 0.00 | -15.87B | -5.31B | -822.00M | -1.10B | -42.00M |
Financing Cash Flow | 0.00 | -5.64B | -5.64B | -6.14B | -3.83B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $198.68B | 14.65 | 6.22% | 3.75% | 22.01% | -13.47% | |
73 Outperform | €172.46B | 29.17 | 10.40% | 0.90% | -10.90% | -19.72% | |
72 Outperform | ¥146.75B | 15.72 | ― | 2.24% | 6.31% | -37.42% | |
69 Neutral | ¥174.93B | 18.51 | ― | 3.19% | 21.20% | 36.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | ¥145.56B | 3.27 | ― | 0.38% | -58.24% | ― |
Fujimi Incorporated reported significant growth in their financial performance for the nine months ending December 31, 2024, with a 23.9% increase in net sales and a substantial rise in operating profit by 48.3%. This financial improvement reflects positively on their market position, indicating a robust recovery from the previous period’s declines and a promising outlook for stakeholders.